• U.S. flag An official website of the United States government
    1. Home

    Drugs

    Topic Paragraphs
    Coronavirus

    CDER is engaged in essential COVID-19 activities to protect and promote public health

    Ranging from the acceleration of development for treatments for COVID-19, maintaining and securing drug supply chains, providing guidance to manufacturers, advising developers on how to handle clinical trial issues, and keeping the public informed

    Learn More

    Navigate the Drugs Section

    Priority Areas & Initiatives

    Opioids

    Reducing the impact of opioid misuse and abuse

    Generics

    Ensuring access to safe, affordable, and effective generic drugs

    Warning Letters

    Warning and Notice of Violation Letters to Pharmaceutical Companies

    Guidances

    FDA's current thinking on drug development and review activities

    Drug Shortages

    Search the database, learn about root causes and potential solutions

    CENTER FOR DRUG EVALUATION AND RESEARCH

    Office of Communications
    10001 New Hampshire Ave
    Hillandale Building, 4th Fl
    Silver Spring, MD 20993

    Toll Free
    (855) 543-3784
    (301) 796-3400

    Hours Available

    CDER Division of Drug Information

    Paragraph Header (Column 2)
    FOR UPDATES ON TWITTER FOLLOW

    @FDA_Drug_Info

    Your source for the latest drug information.
    Know the moment it happens.

    Back to Top
    香港精选资料六肖中特